Questions raised by split vote in pay-for-delay case
As FTC Chairwoman Edith Ramirez spoke with reporters about the Commission’s recent case against several pharmaceutical firms for allegedly scheming to delay consumers’ access to lower-cost generic versions of the drug...To view the full article, register now.
Already a subscriber? Click here to view full article